The core activity of HealthEcon AG is to provide consulting services to the pharmaceutical industry in the field of health technology assessment (HTA), market access, and value strategy in Europe. Specifically, this includes: Consulting on the creation of AMNOG dossiers and other authorization documents, Development of pricing strategies and negotiations with authorities, Creation of international market access plans, Conducting health economic analyses (e.g. cost-benefit analyses, budget impact analyses), Consulting on the planning and implementation of clinical trials, Support in communication with authorities and other stakeholders, Creation of reimbursement dossiers and consulting on price negotiations. The company supports its customers in bridging the gap between regulatory and reimbursement requirements and helps them structure their internal processes and teams.
Outbound Leads by COHAGA